Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.29 EUR | +1.86% | -5.19% | -52.17% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- EYPT Stock
- PV3B Stock
- Charts EyePoint Pharmaceuticals, Inc.